Clinical Trial Update: Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AVE5530 as add-on to ongoing high-dose statins in primary severe hypercholesterolemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AVE5530

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED